Diagnostic options · UAE

Genetics tests in Dubai & UAE

Compare available Genetics tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

2,789

Listed price range

-1.00–50,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Genetics test prices

Showing 2671–2685 of 2,789 matching tests.

Genetics diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-3780 UMOD Gene Hyperuricemic Nephropathy, Familial Juvenile Type 1 Genetic Test This genetic test analyzes the UMOD gene for mutations associated with familial juvenile hyperuricemic nephropathy type 1.	Peripheral whole blood (EDTA), 2–5 mL; also accepted: extracted genomic DNA, FTA card spots	21–28 calendar days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["UMOD gene variants", "Pathogenic and likely-pathogenic variants"] Parameters [] Preparation ["No fasting required", "Inform team of recent blood transfusions, bone marrow transplants, or active malignancies"] Indications ["Suspected familial juvenile hyperuricemic nephropathy type 1", "Family history of early-onset kidney disease or gout", "Need for cascade screening in at-risk relatives"] Measurement technique Confirm with laboratory Codes LOINC: 94487-1 ICD-10: N11.0 Clinical summary This genetic test analyzes the UMOD gene for mutations associated with familial juvenile hyperuricemic nephropathy type 1.
TEST-5961 UMPS Gene Orotic Aciduria Genetic Test This test evaluates the UMPS gene for mutations associated with hereditary orotic aciduria, a rare metabolic disorder.	Peripheral Whole Blood (3-5 mL in EDTA tube) or Buccal Swab	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic mutations in the UMPS gene", "Single nucleotide variants", "Indels", "Copy number variations"] Parameters [] Preparation ["None specified"] Indications ["Suspected hereditary orotic aciduria", "Family history of orotic aciduria", "Evaluation of pyrimidine metabolism disorders"] Measurement technique Confirm with laboratory Codes LOINC: 82863-9 ICD-10: E79.0 Clinical summary This test evaluates the UMPS gene for mutations associated with hereditary orotic aciduria, a rare metabolic disorder.
TEST-5029 UNC13D Gene Hemophagocytic Lymphohistiocytosis Type 3 Genetic Test This test identifies pathogenic variants in the UNC13D gene associated with familial hemophagocytic lymphohistiocytosis type 3 (FHL3).	Peripheral whole blood, Buccal swab, or FTA card	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the UNC13D gene", "Copy Number Variants (CNVs) in the UNC13D gene"] Parameters [] Preparation ["No fasting required", "No medication adjustments required"] Indications ["Suspected familial hemophagocytic lymphohistiocytosis type 3 (FHL3)", "Family history of FHL3", "Consanguinity", "Need for definitive molecular diagnosis for treatment planning (HSCT)", "Genetic counseling and family screening"] Measurement technique Confirm with laboratory Codes LOINC: 82173-8 ICD-10: D76.1 Clinical summary This test identifies pathogenic variants in the UNC13D gene associated with familial hemophagocytic lymphohistiocytosis type 3 (FHL3).
TEST-3062 UPB1 Gene Beta-Ureidopropionase Deficiency Genetic Test This genetic test evaluates the UPB1 gene for mutations associated with beta-ureidopropionase deficiency.	Peripheral Blood, Extracted DNA, or FTA Card Dried Blood Spot	3–4 Weeks (21–28 Business Days)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["UPB1 gene sequence", "Single nucleotide variants", "Insertions/deletions", "Copy number variations"] Parameters [] Preparation [] Indications ["Infants, children, or adults presenting with symptoms suggestive of a pyrimidine disorder", "Carrier screening in families with a known UPB1 mutation", "At-risk relatives seeking clarity"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: E79.8 Clinical summary This genetic test evaluates the UPB1 gene for mutations associated with beta-ureidopropionase deficiency.
TEST-6127 UPB1 Gene Beta‑Ureidopropionase Deficiency Genetic Test This genetic test identifies pathogenic variants in the UPB1 gene, which are responsible for beta‑ureidopropionase deficiency, an inborn error of pyrimidine metabolism.	Peripheral whole blood (3–5 mL in EDTA tube) or FTA card	3–4 weeks (21–28 calendar days)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the UPB1 gene", "Coding region and splice sites of the beta‑ureidopropionase gene"] Parameters [] Preparation ["Do not discontinue prescribed therapy without physician approval"] Indications ["Suspected beta‑ureidopropionase deficiency", "Family history of beta‑ureidopropionase deficiency", "Evaluation of inborn errors of pyrimidine metabolism"] Measurement technique Confirm with laboratory Codes LOINC: 82324-2 ICD-10: E79.89 Clinical summary This genetic test identifies pathogenic variants in the UPB1 gene, which are responsible for beta‑ureidopropionase deficiency, an inborn error of pyrimidine metabolism.
TEST-5065 UQCC2 Gene (Mitochondrial Complex III Deficiency, Nuclear Type 7) Genetic Test This genetic test identifies pathogenic variants in the UQCC2 gene associated with mitochondrial complex III deficiency, nuclear type 7.	Whole blood, extracted DNA, or FTA card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the UQCC2 gene"] Parameters [] Preparation ["Genetic counselling is mandatory before testing"] Indications ["Diagnosis of mitochondrial complex III deficiency, nuclear type 7", "Carrier screening", "Family planning"] Measurement technique Confirm with laboratory Codes LOINC: 48776-7 ICD-10: E88.40, G71.3, Z13.79 Clinical summary This genetic test identifies pathogenic variants in the UQCC2 gene associated with mitochondrial complex III deficiency, nuclear type 7.
TEST-2537 UQCC2 Single-Gene NGS Test for Mitochondrial Complex III Deficiency, Nuclear Type 7 This test identifies pathogenic variants in the UQCC2 gene, confirming the diagnosis of nuclear type 7 mitochondrial complex III deficiency.	Peripheral whole blood or FTA card blood spot	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the UQCC2 gene"] Parameters [] Preparation ["No fasting required", "Inform of any anticoagulant therapy"] Indications ["Suspected UQCC2-related mitochondrial complex III deficiency", "Family history of mitochondrial disease", "Need for accurate genetic counseling and family planning"] Measurement technique Confirm with laboratory Codes LOINC: 96409-4 ICD-10: E88.89 Clinical summary This test identifies pathogenic variants in the UQCC2 gene, confirming the diagnosis of nuclear type 7 mitochondrial complex III deficiency.
TEST-5056 UQCRB Gene Test This test evaluates the UQCRB gene for pathogenic variants associated with mitochondrial complex III deficiency.	Peripheral Whole Blood	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["UQCRB gene pathogenic variants", "Mitochondrial complex III function"] Parameters [] Preparation [] Indications ["Clinical suspicion for mitochondrial complex III deficiency", "Neurological evaluation"] Measurement technique Confirm with laboratory Codes LOINC: 72296-1 ICD-10: E88.49 Clinical summary This test evaluates the UQCRB gene for pathogenic variants associated with mitochondrial complex III deficiency.
TEST-5161 UQCRC2 Gene Mitochondrial Complex III Deficiency Genetic Test This test identifies pathogenic variants within the UQCRC2 gene, which are associated with mitochondrial complex III deficiency, a rare neurometabolic disorder.	Peripheral whole blood (3–5 mL in EDTA tube), or extracted genomic DNA, or FTA card spot.	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the UQCRC2 gene", "Point mutations", "Indels", "Copy-number variants"] Parameters [] Preparation [] Indications ["Suspected mitochondrial complex III deficiency", "Family screening for UQCRC2 mutations"] Measurement technique Confirm with laboratory Codes LOINC: 92653-0 ICD-10: E88.49 Clinical summary This test identifies pathogenic variants within the UQCRC2 gene, which are associated with mitochondrial complex III deficiency, a rare neurometabolic disorder.
TEST-5061 UQCRQ Gene Mitochondrial Complex III Deficiency Genetic Test This test identifies pathogenic variants in the UQCRQ gene associated with mitochondrial complex III deficiency.	Peripheral whole blood (venipuncture)	3 to 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["UQCRQ gene sequence", "Deletions/Duplications in UQCRQ gene"] Parameters [] Preparation [] Indications ["Family history of mitochondrial disease", "Suspected mitochondrial complex III deficiency"] Measurement technique Confirm with laboratory Codes LOINC: 48018-6 ICD-10: E88.49 Clinical summary This test identifies pathogenic variants in the UQCRQ gene associated with mitochondrial complex III deficiency.
TEST-5941 UROC1 Gene Urocanase Deficiency Genetic Test This genetic test detects pathogenic variants in the UROC1 gene associated with urocanase deficiency.	Whole blood (3-5 ml in EDTA tube) or extracted DNA	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the UROC1 gene", "Copy Number Variations (CNV) in the UROC1 gene"] Parameters [] Preparation [] Indications ["Suspected urocanase deficiency", "Family history of UROC1-related disorders", "Unexplained neurological symptoms"] Measurement technique Confirm with laboratory Codes LOINC: 89278-4 ICD-10: E72.8 Clinical summary This genetic test detects pathogenic variants in the UROC1 gene associated with urocanase deficiency.
TEST-5933 UROS Gene Congenital Erythropoietic Porphyria (CEP) Genetic Test This genetic test analyzes the UROS gene for pathogenic variants associated with Congenital Erythropoietic Porphyria (CEP). It identifies mutations causing this rare metabolic diso...	Peripheral Whole Blood or FTA Card (DNA)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the UROS gene", "SNVs, indels, CNVs"] Parameters [] Preparation ["No specific fasting required", "Do not discontinue prescribed medication without consulting your doctor"] Indications ["Clinical suspicion of Congenital Erythropoietic Porphyria (CEP)", "Positive family history of CEP", "Severe photosensitivity presenting in infancy", "Hemolytic anemia with photosensitivity"] Measurement technique Confirm with laboratory Codes LOINC: 21671-7 ICD-10: E80.0 Clinical summary This genetic test analyzes the UROS gene for pathogenic variants associated with Congenital Erythropoietic Porphyria (CEP). It identifies mutations causing this rare metabolic disorder characterized by photosensitivity and hemolytic anemia.
TEST-4648 USB1 Gene Poikiloderma with Neutropenia (Clericuzio Type) Genetic Test This genetic test analyzes the USB1 gene to identify pathogenic variants associated with Clericuzio-type poikiloderma with neutropenia.	3 mL peripheral whole blood in EDTA (purple-top) tube	3–4 weeks from sample receipt	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["USB1 gene coding regions", "USB1 gene splice junctions"] Parameters [] Preparation [] Indications ["Suspected Clericuzio-type poikiloderma with neutropenia", "Family history of the disorder"] Measurement technique Confirm with laboratory Codes LOINC: 81272-4 ICD-10: Q82.8 Clinical summary This genetic test analyzes the USB1 gene to identify pathogenic variants associated with Clericuzio-type poikiloderma with neutropenia.
TEST-5656 USH1C Gene (DFNB18) Sequencing: Autosomal Recessive Deafness Type 18 Genetic Test This test analyzes the USH1C gene to detect mutations associated with autosomal recessive deafness type 18 (DFNB18) and Usher syndrome type 1C.	Whole Blood (3–5 mL EDTA tube), Extracted DNA, or Dried Blood Spot (FTA Card)	3 – 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the USH1C gene", "Coverage of coding exons, intron-exon boundaries, and deep intronic regions"] Parameters [] Preparation ["No fasting required", "Inform phlebotomist about bleeding tendencies or anticoagulant use"] Indications ["Individuals with congenital hearing loss", "Individuals with a family history of hereditary deafness", "Individuals with clinical features suggestive of Usher syndrome"] Measurement technique Confirm with laboratory Codes LOINC: 94227-2 ICD-10: H90.3, H90.5 Clinical summary This test analyzes the USH1C gene to detect mutations associated with autosomal recessive deafness type 18 (DFNB18) and Usher syndrome type 1C.
TEST-5789 USP8 Gene NGS Test for SPG59 (Hereditary Spastic Paraplegia Type 59) This diagnostic test evaluates the USP8 gene for variants associated with Hereditary Spastic Paraplegia Type 59 (SPG59).	Whole Blood (EDTA) or DNA (extracted)	21–28 days from sample receipt	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["USP8 gene variants", "Single-nucleotide variants", "Small indels", "Copy-number changes"] Parameters [] Preparation ["No specific fasting required", "Do not discontinue prescribed medication without consulting your doctor"] Indications ["Suspected Hereditary Spastic Paraplegia Type 59 (SPG59)", "Family history of SPG59"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: G11.4 Clinical summary This diagnostic test evaluates the USP8 gene for variants associated with Hereditary Spastic Paraplegia Type 59 (SPG59).

Category overview

Genetics: overview

Understanding your unique biological blueprint offers a profound sense of clarity and empowers proactive health planning for you and your family. At DNA Labs UAE, our specialized Genetics division employs state-of-the-art molecular technologies to provide deep insights into hereditary markers and cellular mutations. This comprehensive genetics testing in the UAE equips your healthcare provider with the precise data needed to tailor your medical guidance effectively. Recognized among top diagnostic labs in Dubai and the UAE, we prioritize your peace of mind through strict confidentiality protocols and exceptionally fast, accurate reporting. Take the next step in your health journey. View our genetics diagnostic services, book a private home collection, or consult our specialized team today.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.

Explore this area

Genetics tests in Dubai & UAE

Genetics test prices

Genetics: overview

Use the test details as a conversation starter

Related Genetics categories